Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease. (2022)

First Author: HPS3/TIMI55-REVEAL Collaborative Group
Attributed to:  Randomised trials in cardiovascular and metabolic disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/eurheartj/ehab863

PubMed Identifier: 34910136

Publication URI: http://europepmc.org/abstract/MED/34910136

Type: Journal Article/Review

Volume: 43

Parent Publication: European heart journal

Issue: 14

ISSN: 0195-668X